Bills / H.R. 1796
H.R. 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
In plain English
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 This bill reauthorizes through FY2029 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve prevention and treatment of sickle cell disease and complications from the disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
Congressional Research Service summary from Congress.gov (not yet simplified).
Sponsor and status
Loading from Congress.gov…
How South Carolina voted
No recorded roll-call vote on this bill yet. Most bills never get one.
Who lobbied
Lobbying reports name the bills a client worked on. They don't say which side anyone took.
No lobbying reported on this bill in the reports we have loaded (January 2025 through September 2026). Lobbyists report each quarter, about 20 days after it ends, so any lobbying since October 2026 will be added once those reports are filed.